The ProtecT randomised trial cost-effectiveness analysis comparing active monitoring, surgery, or radiotherapy for prostate cancer

BACKGROUND: There is limited evidence relating to the cost-effectiveness of treatments for localised prostate cancer. METHODS: The cost-effectiveness of active monitoring, surgery, and radiotherapy was evaluated within the Prostate Testing for Cancer and Treatment (ProtecT) randomised controlled tri...

Full description

Saved in:
Bibliographic Details
Published in:Br J Cancer
Main Authors: Noble, Sian M., Garfield, Kirsty, Lane, J. Athene, Metcalfe, Chris, Davis, Michael, Walsh, Eleanor I., Martin, Richard M., Turner, Emma L., Peters, Tim J., Thorn, Joanna C., Mason, Malcolm, Bollina, Prasad, Catto, James W. F., Doherty, Alan, Gnanapragasam, Vincent, Hughes, Owen, Kockelbergh, Roger, Kynaston, Howard, Paul, Alan, Paez, Edgar, Rosario, Derek J., Rowe, Edward, Oxley, Jon, Staffurth, John, Neal, David E., Hamdy, Freddie C., Donovan, Jenny L.
Format: Artigo
Language:Inglês
Published: Nature Publishing Group UK 2020
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7524753/
https://ncbi.nlm.nih.gov/pubmed/32669672
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-020-0978-4
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items